Evidence map›Paper›PMID 32339066›Full record

ArticleThe Journal of international medical research2020

Long noncoding RNA MACC1-AS1 promotes the stemness of hepatocellular carcinoma cells by antagonizing miR-145.

Yuling Guo, Jiuhong Zhong, Fang Wu, Zhengyu Zhan

Abstract read
In one paragraph

Article in The Journal of international medical research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Making Sense of Antisense lncRNAs in Hepatocellular Carcinoma.International journal of molecular sciences · 2023
    Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yuling GuoDepartment of Oncology, the First Affiliated Hospital of Nanchang University, Nanchang City, Jiangxi Province, People's Republic of China.
Jiuhong ZhongDepartment of Oncology, the First Affiliated Hospital of Nanchang University, Nanchang City, Jiangxi Province, People's Republic of China.
Fang WuDepartment of Oncology, the First Affiliated Hospital of Nanchang University, Nanchang City, Jiangxi Province, People's Republic of China.
Zhengyu ZhanDepartment of Oncology, the First Affiliated Hospital of Nanchang University, Nanchang City, Jiangxi Province, People's Republic of China.ORCID https://orcid.org/0000-0001-8941-2615

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultAgedCarcinoma, HepatocellularCell Line, TumorCell ProliferationFemaleGene Expression Regulation, NeoplasticHumansLiver NeoplasmsMaleMicroRNAsMiddle AgedNeoplastic Stem CellsRNA, AntisenseRNA, Long NoncodingTrans-ActivatorsMACC1 protein, humanMicroRNAsMIRN145 microRNA, humanRNA, AntisenseRNA, Long NoncodingTrans-Activatorscancer stem cellhepatocellular carcinomaLncRNAMACC1-AS1miR-145stemness

Identifiers

PMID32339066
PMCPMC7218950

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.